Is Haemonetics’ (HAE) ESOP Shelf Move Reframing Its Balance Between Growth Investment and Shareholder Dilution?Simplywall·1 day ago, 10:49 PMHAE-0.18%
Haemonetics Shares Hit New 52-Week High: What's Happening?benzinga_article·2 days ago, 12:12 PMHAE-0.18%CSLLY+2.18%
Haemonetics (NYSE:HAE) Price Target Raised to $110.00 at BTIG ResearchMarket Beat·2 days ago, 09:18 AMHAE-0.18%
Haemonetics: CSL Plasma Migration Deal Highlights Long-Term Upside but Near-Term Risk/Reward Keeps Rating at HoldTip Ranks·2 days ago, 08:55 AMHAE-0.18%CSLLY+2.18%
Haemonetics signs non-exclusive US plasma supply deal with CSL Plasma for NexSys PCS devices, disposablesPUBT·2 days ago, 05:06 AMHAE-0.18%CSLLY+2.18%
Haemonetics Corporation Stock 12‑Month Price Target Raised to $98.9, Implies 10% UpsideTradingView·2 days ago, 04:20 AMHAE-0.18%
Assenagon Asset Management S.A. Sells 142,292 Shares of Haemonetics Corporation $HAEMarket Beat·Aug 14 at 02:12 AMHAE-0.18%
Biotech Stocks At 52-Week Highs - BIVI +22%, XNCR, ANRO, HAE, ACADrttnews·Aug 13 at 03:30 AMANRO-1.83%ACAD-3.87%
Haemonetics (NYSE:HAE) Given New $92.00 Price Target at CitigroupMarket Beat·Aug 7 at 04:12 PMHAE-0.18%
HAE: Revenue grew 5.6% with strong segment performance, Vivasure acquisition, and robust liquidityQuartr·Aug 6 at 06:25 AMHAE-0.18%
Haemonetics Q1 Profit Declines, But Revenue Rises; Raises FY Revenue Outlookrttnews·Aug 6 at 05:55 AMHAE-0.18%
Heamonetics | 8-K: FY2027 Q1 Revenue Beats Estimate at USD 339.38 MEarnings Watch·Aug 6 at 05:12 AMHAE-0.18%
Haemonetics FY27 Q1 adjusted EPS rises 3.6% to $1.14; revenue climbs 5.6% to $339.4 millionPUBT·Aug 6 at 05:01 AMHAE-0.18%
